查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1446424

生命科学分析软体市场：按产品、按应用、按交付模式、按组件、按最终用户：2023-2032 年全球市场机会分析和产业预测

Life Science Analytics Software Market By Product, By Aplication, By Delivery Model, By Component, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 219 Pages | 商品交期: 2-3个工作天内

价格
生命科学分析软体市场-IMG1

生命科学分析在从大型资料集提取有意义的见解方面发挥关键作用。

生命科学分析采用先进的分析技术、机器学习演算法和统计模型来分析生物、临床和基因组资料。生命科学分析初级研究的目的是揭示这些资料集集中的模式、趋势和相关性，使研究人员、医疗保健专业人员和组织能够做出明智的决策和发现。生命科学分析的应用多种多样，包括药物发现、个人化医疗、临床试验优化、医疗保健管理等。透过利用巨量资料，生命科学分析有助于医学研究的进步、对疾病的理解以及更有效和更有针对性的治疗方法的发展。

随着个人化医疗变得越来越重要，并且生命科学分析软体越来越多地用于药物发现和药物开发，生命科学分析软体市场预计将显着增长。对个人化医疗的需求不断增长已成为推动生命科学分析软体市场成长的关键因素。个人化医疗的特征是根据每位患者的特征治疗方法，代表了医疗保健领域的模式转移。例如，国家医学图书馆 2023 年的一份报告指出，由于了解个体之间生物差异的技术取得了重大进步，个人化医疗在过去十年中受到了极大的关注。

个人化医疗具有许多潜在的好处，包括最大限度地降低药物毒性风险、增加所用药物的益处、促进医疗保健系统的平衡以及促进药物发现和开发计划。随着基因组学和分子生物学的不断进步，人们越来越认识到一刀切的医学方法不再是最佳选择。相反，医疗保健提供者正在转向个人化医疗，利用患者基因、生活方式和其他个人因素的洞察来设计更有针对性和更有效的治疗策略。它的目的就是这样做。这些个人化医疗方法产生的资料的复杂性和数据量需要复杂的分析工具。生命科学分析软体在分析和解释复杂的生物资料方面发挥关键作用，使医疗保健专业人员能够就患者护理做出明智的决策。因此，对个人化医疗的需求不断增长预计将推动生命科学分析软体市场的成长。

此外，医疗保健资料的数量和复杂性不断增加，以及对先进分析工具来分析和解释资料的需求预计将推动市场成长。随着生命科学产业的不断发展，医疗保健资料（包括病患记录、临床试验、基因组资讯等）呈指数级增长，对手动取得有意义的见解提出了重大挑战。美国国家医学图书馆 2023 年的一份报告指出，医疗保健领域 80% 以上的数位资料都是非结构化资料，需要新形式的资料处理和标准化，这对医学研究人员提出了艰鉅的挑战。医疗保健资料的复杂性及其不同的来源和格式需要复杂的分析解决方案来导航大量资料集、发现模式并提取可操作的情报。

随着研究人员和组织努力从这些复杂的资讯中提取有意义的见解，对复杂分析工具的需求激增。生命科学分析软体在管理、分析和解释大量资料方面发挥着至关重要的作用，帮助研究人员和医疗保健专业人员做出明智的决策、识别模式并发现有价值的相关性，从而使数据得以揭示。将高级分析、人工智慧和机器学习整合到这些软体解决方案中进一步增强了它们的能力，使它们能够更准确地分析大量资料。因此，医疗资料的数量和复杂性不断增加已成为推动生命科学分析软体市场成长的强大催化剂。

然而，生命科学分析软体市场面临重大挑战和限制因素，资料隐私和安全成为主要问题。随着业界越来越依赖高阶分析从海量资料集提取有意义的见解，所处理资料的固有敏感性和敏感度已成为关键问题。生命科学公司处理高度敏感的信息，例如患者记录、临床试验资料和专有研究结果。这些资料的数量和复杂性不断增加，使其成为寻求未授权存取和滥用的骇客的有吸引力的目标。因此，资料隐私和安全风险预计将抑制市场成长。此外，生命科学分析软体的技术进步预计将为生命科学分析软体市场提供显着的成长机会。

生命科学分析软体市场按产品、应用、交付模式、组件、最终用户和地区进行细分。依产品划分，可分为说明分析、规范分析、预测性分析。按应用分类，可分为研发、销售和行销支援、监管合规、供应链分析和药物安全检测。

根据提供模式，分为本地和云端。按组件划分，分为软体和服务。依最终用户分为製药和生物技术公司、医疗设备公司、研究中心和第三方管理员（TPAS）。按地区划分，我们有北美（美国、加拿大、墨西哥）、欧洲（德国、英国、英国、义大利、西班牙其他欧洲国家地区）、亚太地区（中国、日本、澳洲、印度、韩国、其他亚太地区），在亚太地区（巴西、日本、阿拉伯、澳洲、印度、韩国和亚太其他地区）进行分析。

相关人员的主要利益

  • 该报告定量分析了 2022 年至 2032 年生命科学分析软体市场分析的细分市场、当前趋势、估计/趋势和动态，以识别生命科学分析软体市场的整体机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析强调买家和供应商帮助相关人员做出利润驱动的商业决策并加强供应商-买家网路的潜力。
  • 生命科学分析软体市场区隔的详细分析有助于确定市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前地位的清晰了解。
  • 该报告包括对区域和全球生命科学分析软体市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

可以使用此报告进行报告客製化（需要额外的成本和时间表）

  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 十字交叉细分市场分析—市场规模与预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）
  • 全球/区域/国家层级参与者的市场占有率分析
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 慢性病增加。
      • 医疗保健产业数位化趋势的成长
      • 製药和生物技术公司越来越多地采用生命科学分析软体。
    • 抑制因素
      • 资料隐私和安全问题
    • 机会
      • 生命科学分析的技术进步

第四章生命科学分析软体市场：依产品

  • 概述
  • 说明分析
  • 预测分析
  • 指示性分析

第五章生命科学分析软体市场：依应用分类

  • 概述
  • 研究与开发
  • 销售/行销支持
  • 药品合规性
  • 供应链分析
  • 药物安全检测

第六章生命科学分析软体市场：依交付模式

  • 概述
  • 本地
  • 云

第七章生命科学分析软体市场：依组成部分

  • 概述
  • 软体
  • 服务

第八章生命科学分析软体市场：依最终用户分类

  • 概述
  • 製药和生物技术公司
  • 医疗设备公司
  • 研究中心
  • 第三方管理员

第九章生命科学分析软体市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第10章竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第十一章 公司简介

  • SAS Institute Inc.
  • Oracle Corporation
  • Accenture
  • IQVIA
  • Cognizant
  • Wipro Limited
  • MaxisIT Incorporated
  • Take Solutions Limited
  • TIBCO Software Inc.
  • ExlService Holdings, Inc.
Product Code: A06209
Life Science Analytics Software Market - IMG1

Life science analytics is playing a crucial role in extracting meaningful insights from vast and complex biological and healthcare datasets. Life science analytics employs advanced analytical techniques, machine learning algorithms, and statistical models to analyze biological, clinical, and genomics data. The primary goal of life science analytics is to uncover patterns, trends, and correlations within these datasets, enabling researchers, healthcare professionals, and organizations to make informed decisions and discoveries. Applications of life science analytics are diverse and include drug discovery, personalized medicine, clinical trial optimization, and healthcare management. By using big data, life science analytics contributes to advancements in medical research, disease understanding, and the development of more effective and targeted treatments.

The life science analytics software market is expected to register significant growth, owing to rise in emphasis on personalized medicine, and high adoption of life science analytics software for drug discovery and development. The rise in demand for personalized medicine has emerged as a pivotal driver propelling the growth of the life science analytics software market. Personalized medicine, characterized by the tailoring of medical treatments to the individual characteristics of each patient, represents a paradigm shift in healthcare. For instance, according to a 2023 report by the National Library of Medicine, it was reported that the personalized medicine has received significant attention in the last decade, as technologies for understanding biological differences between individuals have advanced significantly.

There are numerous potential benefits of personalized medicine, including minimizing the risk of drug toxicity, increasing the benefits of the medicines used, contributing to the balance of the healthcare system, and facilitating drug discovery and development programs. As advancements in genomics and molecular biology continue to unfold, there is an increasing recognition that a one-size-fits-all approach to medical treatment is no longer optimal. Instead, healthcare providers are turning to personalized medicine, leveraging insights from a patient's genetic makeup, lifestyle, and other individual factors to design more targeted and effective treatment strategies. The complexity and volume of data generated by these personalized medicine approaches necessitate advanced analytics tools. Life science analytics software plays a crucial role in analyzing and interpreting intricate biological data, enabling healthcare professionals to make informed decisions about patient care. Thus, rise in demand for personalized medicine is expected to drive the growth of the life science analytics software market.

Furthermore, the increasing volume and complexity of healthcare data and need of advanced analytical tools to analyze and interpretate the data is expected to drive the growth of the market. As the life sciences industry continues to evolve, the exponential growth of healthcare data, encompassing patient records, clinical trials, genomic information, and more, poses a significant challenge in deriving meaningful insights manually. According to a 2023 report by the National Library of Medicine, it was reported that over 80% of digital data in healthcare is available as unstructured data, requiring new forms of data processing and standardizing that prove challenging to health researchers. The intricate nature of healthcare data, with its diverse sources and formats, demands sophisticated analytical solutions that can navigate through vast datasets, uncover patterns, and extract actionable intelligence.

As researchers and organizations strive to extract meaningful insights from this complex set of information, the demand for sophisticated analytics tools has soared. Life science analytics software plays a pivotal role in managing, analyzing, and interpreting this vast array of data, enabling researchers and healthcare professionals to make informed decisions, identify patterns, and uncover valuable correlations. The integration of advanced analytics, artificial intelligence, and machine learning within these software solutions further enhances their capabilities, facilitating more accurate analysis of the large set of data. Thus, the escalating volume and complexity of healthcare data serves as a compelling catalyst propelling the growth of the life science analytics software market.

However, the life science analytics software market faces significant challenges and restraints, with data privacy and security emerging as major concerns. As the industry increasingly relies on advanced analytics to extract meaningful insights from vast datasets, the inherent sensitivity and confidentiality of the data being processed become critical issues. Life science organizations deal with highly sensitive information, including patient records, clinical trial data, and proprietary research findings. The growing volume and complexity of this data make it an attractive target for hackers seeking unauthorized access or exploitation. Thus, the data privacy and security risk are expected to restrain the growth of the market. Moreover, the technological advancement in the life science analytics software is expected to present significant growth opportunities in the life science analytics software market.

The life science analytics software market is segmented on the basis of product, application, delivery model, component, end user and region. By product, it is divided into descriptive analytics, prescriptive analytics and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance.

On the basis of delivery model, it is bifurcated into on-premise and cloud. By component, it is segmented into software and services. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers and third-party administrators (TPAS). Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are SAS Institute Inc., Oracle Corporation, Accenture, Cognizant, Wipro Limited, MaxisIT, Inc., Take Solutions, ExlService Holdings, Inc., Tibco Software Inc, and IQVIA.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the life science analytics software market analysis from 2022 to 2032 to identify the prevailing life science analytics software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the life science analytics software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global life science analytics software market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level
  • SWOT Analysis

Key Market Segments

By Product

  • Prescriptive analytics
  • Descriptive analytics
  • Predictive Analytics

By Aplication

  • Research and development
  • Sales and marketing support
  • Regulatory compliance
  • Supply chain analytics
  • Pharmacovigilance

By Delivery Model

  • On-premise
  • Cloud

By Component

  • Software
  • Services

By End User

  • Pharmaceutical and biotechnology companies
  • Medical device companies
  • Research centers
  • Third party administrators

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Oracle Corporation
    • Accenture
    • Cognizant
    • Wipro Limited
    • MaxisIT Incorporated
    • TIBCO Software Inc.
    • IQVIA
    • Take Solutions Limited
    • SAS Institute Inc.
    • ExlService Holdings, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of chronic diseases.
      • 3.4.1.2. Growth in trend of digitization in healthcare industry.
      • 3.4.1.3. Rise in adoption of life science analytics software by pharmaceutical and biotechnology companies.
    • 3.4.2. Restraints
      • 3.4.2.1. Data privacy and security concerns.
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancements in life science analytics.

CHAPTER 4: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Descriptive analytics
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Predictive Analytics
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Prescriptive analytics
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Research and development
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Sales and marketing support
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Regulatory compliance
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Supply chain analytics
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Pharmacovigilance
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. On-premise
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Cloud
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Software
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Services
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country

CHAPTER 8: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Pharmaceutical and biotechnology companies
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. Medical device companies
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. Research centers
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country
  • 8.5. Third party administrators
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by region
    • 8.5.3. Market share analysis by country

CHAPTER 9: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION

  • 9.1. Overview
    • 9.1.1. Market size and forecast By Region
  • 9.2. North America
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by Product
    • 9.2.3. Market size and forecast, by Aplication
    • 9.2.4. Market size and forecast, by Delivery Model
    • 9.2.5. Market size and forecast, by Component
    • 9.2.6. Market size and forecast, by End User
    • 9.2.7. Market size and forecast, by country
      • 9.2.7.1. U.S.
      • 9.2.7.1.1. Market size and forecast, by Product
      • 9.2.7.1.2. Market size and forecast, by Aplication
      • 9.2.7.1.3. Market size and forecast, by Delivery Model
      • 9.2.7.1.4. Market size and forecast, by Component
      • 9.2.7.1.5. Market size and forecast, by End User
      • 9.2.7.2. Canada
      • 9.2.7.2.1. Market size and forecast, by Product
      • 9.2.7.2.2. Market size and forecast, by Aplication
      • 9.2.7.2.3. Market size and forecast, by Delivery Model
      • 9.2.7.2.4. Market size and forecast, by Component
      • 9.2.7.2.5. Market size and forecast, by End User
      • 9.2.7.3. Mexico
      • 9.2.7.3.1. Market size and forecast, by Product
      • 9.2.7.3.2. Market size and forecast, by Aplication
      • 9.2.7.3.3. Market size and forecast, by Delivery Model
      • 9.2.7.3.4. Market size and forecast, by Component
      • 9.2.7.3.5. Market size and forecast, by End User
  • 9.3. Europe
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by Product
    • 9.3.3. Market size and forecast, by Aplication
    • 9.3.4. Market size and forecast, by Delivery Model
    • 9.3.5. Market size and forecast, by Component
    • 9.3.6. Market size and forecast, by End User
    • 9.3.7. Market size and forecast, by country
      • 9.3.7.1. Germany
      • 9.3.7.1.1. Market size and forecast, by Product
      • 9.3.7.1.2. Market size and forecast, by Aplication
      • 9.3.7.1.3. Market size and forecast, by Delivery Model
      • 9.3.7.1.4. Market size and forecast, by Component
      • 9.3.7.1.5. Market size and forecast, by End User
      • 9.3.7.2. France
      • 9.3.7.2.1. Market size and forecast, by Product
      • 9.3.7.2.2. Market size and forecast, by Aplication
      • 9.3.7.2.3. Market size and forecast, by Delivery Model
      • 9.3.7.2.4. Market size and forecast, by Component
      • 9.3.7.2.5. Market size and forecast, by End User
      • 9.3.7.3. UK
      • 9.3.7.3.1. Market size and forecast, by Product
      • 9.3.7.3.2. Market size and forecast, by Aplication
      • 9.3.7.3.3. Market size and forecast, by Delivery Model
      • 9.3.7.3.4. Market size and forecast, by Component
      • 9.3.7.3.5. Market size and forecast, by End User
      • 9.3.7.4. Italy
      • 9.3.7.4.1. Market size and forecast, by Product
      • 9.3.7.4.2. Market size and forecast, by Aplication
      • 9.3.7.4.3. Market size and forecast, by Delivery Model
      • 9.3.7.4.4. Market size and forecast, by Component
      • 9.3.7.4.5. Market size and forecast, by End User
      • 9.3.7.5. Spain
      • 9.3.7.5.1. Market size and forecast, by Product
      • 9.3.7.5.2. Market size and forecast, by Aplication
      • 9.3.7.5.3. Market size and forecast, by Delivery Model
      • 9.3.7.5.4. Market size and forecast, by Component
      • 9.3.7.5.5. Market size and forecast, by End User
      • 9.3.7.6. Rest of Europe
      • 9.3.7.6.1. Market size and forecast, by Product
      • 9.3.7.6.2. Market size and forecast, by Aplication
      • 9.3.7.6.3. Market size and forecast, by Delivery Model
      • 9.3.7.6.4. Market size and forecast, by Component
      • 9.3.7.6.5. Market size and forecast, by End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key market trends, growth factors and opportunities
    • 9.4.2. Market size and forecast, by Product
    • 9.4.3. Market size and forecast, by Aplication
    • 9.4.4. Market size and forecast, by Delivery Model
    • 9.4.5. Market size and forecast, by Component
    • 9.4.6. Market size and forecast, by End User
    • 9.4.7. Market size and forecast, by country
      • 9.4.7.1. Japan
      • 9.4.7.1.1. Market size and forecast, by Product
      • 9.4.7.1.2. Market size and forecast, by Aplication
      • 9.4.7.1.3. Market size and forecast, by Delivery Model
      • 9.4.7.1.4. Market size and forecast, by Component
      • 9.4.7.1.5. Market size and forecast, by End User
      • 9.4.7.2. China
      • 9.4.7.2.1. Market size and forecast, by Product
      • 9.4.7.2.2. Market size and forecast, by Aplication
      • 9.4.7.2.3. Market size and forecast, by Delivery Model
      • 9.4.7.2.4. Market size and forecast, by Component
      • 9.4.7.2.5. Market size and forecast, by End User
      • 9.4.7.3. India
      • 9.4.7.3.1. Market size and forecast, by Product
      • 9.4.7.3.2. Market size and forecast, by Aplication
      • 9.4.7.3.3. Market size and forecast, by Delivery Model
      • 9.4.7.3.4. Market size and forecast, by Component
      • 9.4.7.3.5. Market size and forecast, by End User
      • 9.4.7.4. Rest of Asia-Pacific
      • 9.4.7.4.1. Market size and forecast, by Product
      • 9.4.7.4.2. Market size and forecast, by Aplication
      • 9.4.7.4.3. Market size and forecast, by Delivery Model
      • 9.4.7.4.4. Market size and forecast, by Component
      • 9.4.7.4.5. Market size and forecast, by End User
  • 9.5. LAMEA
    • 9.5.1. Key market trends, growth factors and opportunities
    • 9.5.2. Market size and forecast, by Product
    • 9.5.3. Market size and forecast, by Aplication
    • 9.5.4. Market size and forecast, by Delivery Model
    • 9.5.5. Market size and forecast, by Component
    • 9.5.6. Market size and forecast, by End User
    • 9.5.7. Market size and forecast, by country
      • 9.5.7.1. Brazil
      • 9.5.7.1.1. Market size and forecast, by Product
      • 9.5.7.1.2. Market size and forecast, by Aplication
      • 9.5.7.1.3. Market size and forecast, by Delivery Model
      • 9.5.7.1.4. Market size and forecast, by Component
      • 9.5.7.1.5. Market size and forecast, by End User
      • 9.5.7.2. Saudi Arabia
      • 9.5.7.2.1. Market size and forecast, by Product
      • 9.5.7.2.2. Market size and forecast, by Aplication
      • 9.5.7.2.3. Market size and forecast, by Delivery Model
      • 9.5.7.2.4. Market size and forecast, by Component
      • 9.5.7.2.5. Market size and forecast, by End User
      • 9.5.7.3. South Africa
      • 9.5.7.3.1. Market size and forecast, by Product
      • 9.5.7.3.2. Market size and forecast, by Aplication
      • 9.5.7.3.3. Market size and forecast, by Delivery Model
      • 9.5.7.3.4. Market size and forecast, by Component
      • 9.5.7.3.5. Market size and forecast, by End User
      • 9.5.7.4. Rest of LAMEA
      • 9.5.7.4.1. Market size and forecast, by Product
      • 9.5.7.4.2. Market size and forecast, by Aplication
      • 9.5.7.4.3. Market size and forecast, by Delivery Model
      • 9.5.7.4.4. Market size and forecast, by Component
      • 9.5.7.4.5. Market size and forecast, by End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top winning strategies
  • 10.3. Product mapping of top 10 player
  • 10.4. Competitive dashboard
  • 10.5. Competitive heatmap
  • 10.6. Top player positioning, 2022

CHAPTER 11: COMPANY PROFILES

  • 11.1. SAS Institute Inc.
    • 11.1.1. Company overview
    • 11.1.2. Key executives
    • 11.1.3. Company snapshot
    • 11.1.4. Operating business segments
    • 11.1.5. Product portfolio
    • 11.1.6. Key strategic moves and developments
  • 11.2. Oracle Corporation
    • 11.2.1. Company overview
    • 11.2.2. Key executives
    • 11.2.3. Company snapshot
    • 11.2.4. Operating business segments
    • 11.2.5. Product portfolio
    • 11.2.6. Business performance
    • 11.2.7. Key strategic moves and developments
  • 11.3. Accenture
    • 11.3.1. Company overview
    • 11.3.2. Key executives
    • 11.3.3. Company snapshot
    • 11.3.4. Operating business segments
    • 11.3.5. Product portfolio
    • 11.3.6. Business performance
    • 11.3.7. Key strategic moves and developments
  • 11.4. IQVIA
    • 11.4.1. Company overview
    • 11.4.2. Key executives
    • 11.4.3. Company snapshot
    • 11.4.4. Operating business segments
    • 11.4.5. Product portfolio
    • 11.4.6. Business performance
  • 11.5. Cognizant
    • 11.5.1. Company overview
    • 11.5.2. Key executives
    • 11.5.3. Company snapshot
    • 11.5.4. Operating business segments
    • 11.5.5. Product portfolio
    • 11.5.6. Business performance
  • 11.6. Wipro Limited
    • 11.6.1. Company overview
    • 11.6.2. Key executives
    • 11.6.3. Company snapshot
    • 11.6.4. Operating business segments
    • 11.6.5. Product portfolio
    • 11.6.6. Business performance
    • 11.6.7. Key strategic moves and developments
  • 11.7. MaxisIT Incorporated
    • 11.7.1. Company overview
    • 11.7.2. Key executives
    • 11.7.3. Company snapshot
    • 11.7.4. Operating business segments
    • 11.7.5. Product portfolio
  • 11.8. Take Solutions Limited
    • 11.8.1. Company overview
    • 11.8.2. Key executives
    • 11.8.3. Company snapshot
    • 11.8.4. Operating business segments
    • 11.8.5. Product portfolio
    • 11.8.6. Business performance
  • 11.9. TIBCO Software Inc.
    • 11.9.1. Company overview
    • 11.9.2. Key executives
    • 11.9.3. Company snapshot
    • 11.9.4. Operating business segments
    • 11.9.5. Product portfolio
  • 11.10. ExlService Holdings, Inc.
    • 11.10.1. Company overview
    • 11.10.2. Key executives
    • 11.10.3. Company snapshot
    • 11.10.4. Operating business segments
    • 11.10.5. Product portfolio
    • 11.10.6. Business performance
    • 11.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 06. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SALES AND MARKETING SUPPORT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PHARMACOVIGILANCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 12. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR ON-PREMISE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR CLOUD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 15. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR THIRD PARTY ADMINISTRATORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 29. U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 31. U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 32. U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 33. U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 36. CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 37. CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 38. CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 41. MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 42. MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 43. MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 47. EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 48. EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 53. GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 54. GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 57. FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 58. FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 59. FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 60. UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 61. UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 62. UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 63. UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 64. UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 67. ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 68. ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 69. ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 72. SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 73. SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 74. SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 77. REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 78. REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 79. REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 82. ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 83. ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 84. ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 86. JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 88. JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 89. JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 90. JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 91. CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 92. CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 93. CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 94. CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 95. CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 98. INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 99. INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 100. INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 103. REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 104. REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 105. REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 106. LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 107. LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 108. LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 109. LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 110. LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 112. BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 113. BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 114. BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 115. BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 116. BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 118. SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 119. SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 120. SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 121. SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 125. SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 126. SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 127. REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 128. REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022-2032 ($MILLION)
  • TABLE 129. REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022-2032 ($MILLION)
  • TABLE 130. REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 131. REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 132. SAS INSTITUTE INC.: KEY EXECUTIVES
  • TABLE 133. SAS INSTITUTE INC.: COMPANY SNAPSHOT
  • TABLE 134. SAS INSTITUTE INC.: PRODUCT SEGMENTS
  • TABLE 135. SAS INSTITUTE INC.: PRODUCT PORTFOLIO
  • TABLE 136. SAS INSTITUTE INC.: KEY STRATERGIES
  • TABLE 137. ORACLE CORPORATION: KEY EXECUTIVES
  • TABLE 138. ORACLE CORPORATION: COMPANY SNAPSHOT
  • TABLE 139. ORACLE CORPORATION: SERVICE SEGMENTS
  • TABLE 140. ORACLE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 141. ORACLE CORPORATION: KEY STRATERGIES
  • TABLE 142. ACCENTURE: KEY EXECUTIVES
  • TABLE 143. ACCENTURE: COMPANY SNAPSHOT
  • TABLE 144. ACCENTURE: SERVICE SEGMENTS
  • TABLE 145. ACCENTURE: PRODUCT PORTFOLIO
  • TABLE 146. ACCENTURE: KEY STRATERGIES
  • TABLE 147. IQVIA: KEY EXECUTIVES
  • TABLE 148. IQVIA: COMPANY SNAPSHOT
  • TABLE 149. IQVIA: PRODUCT SEGMENTS
  • TABLE 150. IQVIA: PRODUCT PORTFOLIO
  • TABLE 151. COGNIZANT: KEY EXECUTIVES
  • TABLE 152. COGNIZANT: COMPANY SNAPSHOT
  • TABLE 153. COGNIZANT: SERVICE SEGMENTS
  • TABLE 154. COGNIZANT: PRODUCT PORTFOLIO
  • TABLE 155. WIPRO LIMITED: KEY EXECUTIVES
  • TABLE 156. WIPRO LIMITED: COMPANY SNAPSHOT
  • TABLE 157. WIPRO LIMITED: PRODUCT SEGMENTS
  • TABLE 158. WIPRO LIMITED: SERVICE SEGMENTS
  • TABLE 159. WIPRO LIMITED: PRODUCT PORTFOLIO
  • TABLE 160. WIPRO LIMITED: KEY STRATERGIES
  • TABLE 161. MAXISIT INCORPORATED: KEY EXECUTIVES
  • TABLE 162. MAXISIT INCORPORATED: COMPANY SNAPSHOT
  • TABLE 163. MAXISIT INCORPORATED: PRODUCT SEGMENTS
  • TABLE 164. MAXISIT INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 165. TAKE SOLUTIONS LIMITED: KEY EXECUTIVES
  • TABLE 166. TAKE SOLUTIONS LIMITED: COMPANY SNAPSHOT
  • TABLE 167. TAKE SOLUTIONS LIMITED: SERVICE SEGMENTS
  • TABLE 168. TAKE SOLUTIONS LIMITED: PRODUCT PORTFOLIO
  • TABLE 169. TIBCO SOFTWARE INC.: KEY EXECUTIVES
  • TABLE 170. TIBCO SOFTWARE INC.: COMPANY SNAPSHOT
  • TABLE 171. TIBCO SOFTWARE INC.: SERVICE SEGMENTS
  • TABLE 172. TIBCO SOFTWARE INC.: PRODUCT PORTFOLIO
  • TABLE 173. EXLSERVICE HOLDINGS, INC.: KEY EXECUTIVES
  • TABLE 174. EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT
  • TABLE 175. EXLSERVICE HOLDINGS, INC.: SERVICE SEGMENTS
  • TABLE 176. EXLSERVICE HOLDINGS, INC.: PRODUCT PORTFOLIO
  • TABLE 177. EXLSERVICE HOLDINGS, INC.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN LIFE SCIENCE ANALYTICS SOFTWARE MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN LIFE SCIENCE ANALYTICS SOFTWARE MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR DESCRIPTIVE ANALYTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PREDICTIVE ANALYTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PRESCRIPTIVE ANALYTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APLICATION, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SALES AND MARKETING SUPPORT, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SUPPLY CHAIN ANALYTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PHARMACOVIGILANCE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR ON-PREMISE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR CLOUD, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COMPONENT, 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 30. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH CENTERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 31. COMPARATIVE SHARE ANALYSIS OF LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR THIRD PARTY ADMINISTRATORS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 32. LIFE SCIENCE ANALYTICS SOFTWARE MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 33. U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: LIFE SCIENCE ANALYTICS SOFTWARE MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2022
  • FIGURE 57. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. ACCENTURE: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 61. ACCENTURE: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 62. ACCENTURE: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. ACCENTURE: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 64. IQVIA: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. IQVIA: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. IQVIA: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 67. COGNIZANT: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 68. COGNIZANT: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 69. WIPRO LIMITED: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 70. WIPRO LIMITED: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 71. WIPRO LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 72. TAKE SOLUTIONS LIMITED: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 73. EXLSERVICE HOLDINGS, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 74. EXLSERVICE HOLDINGS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)